| bDMARDs: TNF inhibitors (etanercept, adalimumab, infliximab, golimumab, certolizumab pegol), T cell costimulatory inhibitor (abatacept), IL-6 receptor inhibitors (tocilizumab, sarilumab), anti-CD20 antibody (rituximab)â€  |
| tsDMARDs: JAK inhibitors (tofacitinib, baricitinib, upadacitinib).                                                                               |